GERNGeron Corporation
$1.21-6.2% 1Y
$1.21
$1.0752 weeks$1.95
GERN in its own filings
GERN's filing record carries 2 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
540
Events found in the filings · across 1,560 filings · the record starts in 1996
- Hard flags
- 2
Hard flags
- Most recent filing
- Aug 6, 2026
Most recent filing · Form 8-K
- Record starts
- Sep 12, 1996
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 4, 2026
- Restatement admitted (non-reliance)historical
- 2007-03-09
- Delisting notice / listing-rule failurehistorical
- 2009-02-12
- SEC comment-letter activity36 occurrences
- 2020-11-04
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights.Earnings release · press release
- May 27, 2026Amendment to 2018 Equity Incentive Plan As further described below, at the 2026 Annual Meeting of Stockholders of Geron Corporation (the “Company”) held on May 20, 2026 (the “2026 Annual Meeting”), the Company’s stockholders approved an amendment and restatement of the Company’s 2018 Equity Incentive Plan to, among …Director or officer change · Form 8-K
- Mar 26, 2026Election of Directors On March 25, 2026, the Board of Directors (the “Board”) of Geron Corporation (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Patricia S. Andrews and Constantine Chinoporos to the Board, in each case effective immediately, and …Director or officer change · Form 8-K
- Feb 25, 2026Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business.Earnings release · press release
- Jan 6, 2026Pharmakon Loan Agreement Amendment On January 5, 2026, Geron Corporation (“we” or the “Company”) entered into that certain first amendment to loan agreement (the “First Amendment Agreement”) with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a “Lender”), which are investment funds …Material agreement entered · Form 8-K
- Dec 16, 2025On December 16, 2025, Geron Corporation (the “Company”) began implementation of a strategic restructuring plan intended to position the Company for long-term value creation for patients and shareholders and improve its financial discipline (the “Plan”)Exit or disposal costs (restructuring) · Form 8-K
- Nov 5, 2025Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights.Earnings release · press release
- Oct 14, 2025Board of Director Departures On October 10, 2025, Gaurav Aggarwal, M.D., notified the Board of Directors (the “Board”) of Geron Corporation (the “Company”) that he is resigning from the Board, effective immediately, due to professional obligations.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…